CIAM
MRKR icon

Caitong International Asset Management’s Marker Therapeutics MRKR Stock Holding History

Caitong International Asset Management’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13 Buy
9
+6
+200% +$9 ﹤0.01% 2600
2026
Q1 		$4 Buy
+3
New +$5 ﹤0.01% 2335

Other funds holding MRKR

CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return

Caitong International Asset Management's MRKR Position: Q2 2026 in Review

Caitong International Asset Management increased its Marker Therapeutics (MRKR) stake by 200% in Q2 2026, buying an estimated $9 and bringing the position to 9 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

Caitong International Asset Management first reported a position in MRKR in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • Caitong International Asset Management held 9 shares of Marker Therapeutics worth $13 as of Q2 2026.
  • Caitong International Asset Management bought 6 Marker Therapeutics shares in Q2 2026, an estimated $9.
  • Marker Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2600 holding.
  • Caitong International Asset Management first reported a position in Marker Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.